Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000892569-02-000686
Filing Date
2002-04-01
Accepted
2002-04-01 00:00:00
Documents
9
Period of Report
2001-12-31

Document Format Files

Seq Description Document Type Size
1 ISTA PHARMACEUTICALS, INC. PERIOD END DEC 31, 2002 a80129e10-k.htm 10-K 805543
3 EXHIBIT 10.26 a80129ex10-26.txt EX-10.26 21280
4 EXHIBIT 10.27 a80129ex10-27.txt EX-10.27 20125
5 EXHIBIT 10.28 a80129ex10-28.txt EX-10.28 51406
6 EXHIBIT 10.29 a80129ex10-29.txt EX-10.29 31799
7 EXHIBIT 10.30 a80129ex10-30.txt EX-10.30 4354
8 EXHIBIT 10.31 a80129ex10-31.txt EX-10.31 29279
9 EXHIBIT 23.1 a80129ex23-1.txt EX-23.1 617
10 GRAPHIC a80129a80129i1.jpg GRAPHIC 7134
  Complete submission text file 0000892569-02-000686.txt   974080
Mailing Address 15279 ALTON PARKWAY 100 IRVINE CA 92618
Business Address 15279 ALTON PARKWAY 100 IRVINE CA 92618 9497886000
ISTA PHARMACEUTICALS INC (Filer) CIK: 0000930553 (see all company filings)

EIN.: 330511719 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-31255 | Film No.: 02597361
SIC: 2835 In Vitro & In Vivo Diagnostic Substances